Managing Comorbidities in Idiopathic Pulmonary Fibrosis

International Journal of General Medicine - New Zealand
doi 10.2147/ijgm.s74880
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa UK Limited

Related search

Impact of Comorbidities on Mortality in Patients With Idiopathic Pulmonary Fibrosis

PLoS ONE
Multidisciplinary
2016English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences
2018English

Serum Biomarkers in Idiopathic Pulmonary Fibrosis

Pulmonary Pharmacology and Therapeutics
BiochemistryMedicinePulmonaryRespiratory MedicinePharmacology
2010English

Cardiovascular Risk in Idiopathic Pulmonary Fibrosis

International Journal of Pulmonary & Respiratory Sciences
2018English

Idiopathic Pulmonary Fibrosis in Monozygotic Twins

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1980English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy